132.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Struggling US healthcare stocks endure rough 2025 but draw some bargain hunters - Reuters
Abbott launches next-gen MitraClip, TriClip G5 systems - MassDevice
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It? - TradingView
Abbott Laboratories' (NYSE:ABT) Earnings Are Of Questionable Quality - Yahoo Finance
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Medical Devices & SuppliesDiversified Stocks Q2 Highlights: Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Is a Favorite Amongst Institutional Investors Who Own 80% - 富途牛牛
Is it the right time to buy Abbott Laboratories stockTremendous wealth creation - jammulinksnews.com
How does Abbott Laboratories compare to its industry peersMaximize portfolio growth with professional advice - Jammu Links News
When is Abbott Laboratories stock expected to show significant growthConsistent high-performance stocks - jammulinksnews.com
UBS Shrugs Abbott Laboratories’ (ABT) Diagnostic Weakness Affirms ‘Buy’ Rating - MSN
RECKITT (RBGLY) URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Reckitt Benckiser Group plc and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Abbott Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st
Stock Analysis | Abbott Laboratories OutlookMixed Signals Amid Strong Fundamentals and Technical Uncertainty - AInvest
Similac NEC Lawsuit: 2025 Updates & List of Affected Formulas - Drugwatch.com
Abbott Laboratories Shares Drop 1.84 as Analysts Clash on Value Amid $850M Volume 155th in Market Activity - AInvest
How volatile is Abbott Laboratories stock compared to the marketMarket Forecast Signals For Fast Growth - Jammu Links News
Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Abbott Laboratories 2025 Q2 Earnings Strong Performance as Net Income Climbs 36.6% - AInvest
Why Abbott Laboratories (ABT) Remains a Buy Despite Diagnostic Segment Weakness - AInvest
Biotechnology Market is evolving rapidly Through 2025 To 2032 | Abbott Laboratories, Amgen Inc., GlaxoSmithKline - openPR.com
Abbott Gains 1.31% Amid 140th Trading Volume Rank as Analysts Weigh Diagnostic Sector Growth and Competitive Risks - AInvest
Meal Replacement Market Is Booming Worldwide 2025-2032 | Abbott - openPR.com
Paul MacDonald's Top Picks: Stryker, Abbott Labs & Elevance Health - BNN Bloomberg
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche - Yahoo Finance
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT) - MSN
2nd Abbott Baby Formula Bellwether Falls Before Trial - Law360
What institutional investors are buying Abbott Laboratories stockMaximize your portfolio’s growth potential - jammulinksnews.com
Does Abbott Laboratories stock perform well during market downturnsBuild a winning investment strategy today - jammulinksnews.com
Leerink Partners Decreases PT on Abbott Laboratories (ABT) to $136 From $143, Maintains a Hold Rating - Insider Monkey
Abbott Laboratories' Q2 Earnings Report Presents Mixed Picture, Leerink Partners Decreases PT to $136, Maintains Hold Rating - AInvest
RBC Capital Bullish on Abbott Laboratories, Raises Price Target to $147. - AInvest
How does Abbott Laboratories generate profit in a changing economyMaximize your returns with portfolio optimization - jammulinksnews.com
Why is Abbott Laboratories stock attracting strong analyst attentionBuild wealth with steady, reliable stocks - jammulinksnews.com
Declining Stock and Solid Fundamentals: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? - Yahoo Finance
Continental Express wins fifth Abbott award - Sidney Daily News
Did Strong Q2 Results and Raised Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative? - simplywall.st
Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity - MSN
What analysts say about Abbott Laboratories stockConsistent high-performance stocks - PrintWeekIndia
Abbott Laboratories Stock Analysis and ForecastDynamic growth stocks - Autocar Professional
What drives Abbott Laboratories stock priceOutstanding capital appreciation - Autocar Professional
Abbott Laboratories (ABT): A Bull Case Theory - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):